Literature DB >> 20142568

Standard care impact on effects of highly active antiretroviral therapy adherence interventions: A meta-analysis of randomized controlled trials.

Marijn de Bruin1, Wolfgang Viechtbauer, Herman P Schaalma, Gerjo Kok, Charles Abraham, Harm J Hospers.   

Abstract

BACKGROUND: Poor adherence to medication limits the effectiveness of treatment for human immunodeficiency virus. Systematic reviews can identify practical and effective interventions. Meta-analyses that control for variability in standard care provided to control groups may produce more accurate estimates of intervention effects.
METHODS: To examine whether viral load and adherence success rates could be accurately explained by the active content of highly active antiretroviral therapy (HAART) adherence interventions when controlling for variability in care delivered to controls, databases were searched for randomized controlled trials of HAART adherence interventions published from 1996 to January 2009. A total of 1342 records were retrieved, and 52 articles were examined in detail. Directly observed therapy and interventions targeting specific patient groups (ie, psychiatric or addicted patients, patients <18 years) were excluded, yielding a final sample of 31 trials. Two coders independently retrieved study details. Authors were contacted to complete missing data.
RESULTS: Twenty studies were included in the analyses. The content of adherence care provided to control and intervention groups predicted viral load and adherence success rates in both conditions (P < .001 for all comparisons), with an estimated impact of optimal adherence care of 55 percentage points. After controlling for variability in care provided to controls, the capacity of the interventions accurately predicted viral load and adherence effect sizes (R(2) = 0.78, P = .02; R(2) = 0.28, P < .01). Although interventions were generally beneficial, their effectiveness reduced noticeably with increasing levels of standard care.
CONCLUSIONS: Intervention and control patients were exposed to effective adherence care. Future meta-analyses of (behavior change) interventions should control for variability in care delivered to active controls. Clinical practice may be best served by implementing current best practice.

Entities:  

Mesh:

Year:  2010        PMID: 20142568     DOI: 10.1001/archinternmed.2009.536

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  72 in total

1.  The forms and functions of peer social support for people living with HIV.

Authors:  Jennifer L Peterson; Lance S Rintamaki; Dale E Brashers; Daena J Goldsmith; Judith L Neidig
Journal:  J Assoc Nurses AIDS Care       Date:  2011-11-13       Impact factor: 1.354

2.  Directly observed antidepressant medication treatment and HIV outcomes among homeless and marginally housed HIV-positive adults: a randomized controlled trial.

Authors:  Alexander C Tsai; Dan H Karasic; Gwendolyn P Hammer; Edwin D Charlebois; Kathy Ragland; Andrew R Moss; James L Sorensen; James W Dilley; David R Bangsberg
Journal:  Am J Public Health       Date:  2012-06-21       Impact factor: 9.308

Review 3.  Cost effectiveness of medication adherence-enhancing interventions: a systematic review of trial-based economic evaluations.

Authors:  Edwin J M Oberjé; Reina J A de Kinderen; Silvia M A A Evers; Cees M J van Woerkum; Marijn de Bruin
Journal:  Pharmacoeconomics       Date:  2013-12       Impact factor: 4.981

4.  Ten-year trends in antiretroviral therapy persistence among US Medicaid beneficiaries.

Authors:  Bora Youn; Theresa I Shireman; Yoojin Lee; Omar Galárraga; Aadia I Rana; Amy C Justice; Ira B Wilson
Journal:  AIDS       Date:  2017-07-31       Impact factor: 4.177

5.  Enhancing Behavior Change Technique Coding Methods: Identifying Behavioral Targets and Delivery Styles in Smoking Cessation Trials.

Authors:  Nicola Black; A Jess Williams; Neza Javornik; Claire Scott; Marie Johnston; Maarten C Eisma; Susan Michie; Jamie Hartmann-Boyce; Robert West; Wolfgang Viechtbauer; Marijn de Bruin
Journal:  Ann Behav Med       Date:  2019-05-03

Review 6.  A role for depression in sexual risk reduction for women? A meta-analysis of HIV prevention trials with depression outcomes.

Authors:  Carter A Lennon; Tania B Huedo-Medina; Daniel P Gerwien; Blair T Johnson
Journal:  Soc Sci Med       Date:  2012-02-24       Impact factor: 4.634

7.  Assessing treatment motivation among patients receiving antiretroviral therapy: a multidimensional approach.

Authors:  Eric Houston; David J McKirnan; Daniel Cervone; Matthew S Johnson; Theo G M Sandfort
Journal:  Psychol Health       Date:  2011-09-23

8.  Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel.

Authors:  Melanie A Thompson; Michael J Mugavero; K Rivet Amico; Victoria A Cargill; Larry W Chang; Robert Gross; Catherine Orrell; Frederick L Altice; David R Bangsberg; John G Bartlett; Curt G Beckwith; Nadia Dowshen; Christopher M Gordon; Tim Horn; Princy Kumar; James D Scott; Michael J Stirratt; Robert H Remien; Jane M Simoni; Jean B Nachega
Journal:  Ann Intern Med       Date:  2012-03-05       Impact factor: 25.391

Review 9.  Effects of integrated interventions on transmission risk and care continuum outcomes in persons living with HIV: meta-analysis, 1996-2014.

Authors:  Nicole Crepaz; Brittney N Baack; Darrel H Higa; Mary M Mullins
Journal:  AIDS       Date:  2015-11-28       Impact factor: 4.177

10.  Determinants of engagement in HIV treatment and care among Zambians new to antiretroviral therapy.

Authors:  Deborah L Jones; Isaac Zulu; Szonja Vamos; Ryan Cook; Ndashi Chitalu; Stephen M Weiss
Journal:  J Assoc Nurses AIDS Care       Date:  2012-09-23       Impact factor: 1.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.